Status:
UNKNOWN
Citrate Anticoagulation During MARS Treatment
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Liver Failure
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The optimal anticoagulation procedure during MARS treatment has not been defined. In various multi-centre trials, such as MARS-RELIEF, anticoagulation procedures are left to the discretion of the trea...
Eligibility Criteria
Inclusion
- Scheduled MARS treatment
- Age over 18 years
- Informed consent
- Admitted to Intensive Care Unit
Exclusion
- Blood or plasma transfusion within 48 hours before study
- Hypocalcemia (ionised Ca \< 0.90 mmol/l)
- Acidosis (pH \< 7.25) due to any cause
- Use of citrate containing medications
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00695617
Start Date
July 1 2008
End Date
December 1 2009
Last Update
March 5 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitaire Ziekenhuizen Leuven
Leuven, Vlaams-Brabant, Belgium, 3000